Efficacy and Safety of a New 10% Topical Minoxidil Versus 5% Topical Minoxidil and Placebo in the Treatment of Male Androgenetic Alopecia: A Trichoscopic Evaluation

August 2019 in “ Journal of Dermatological Treatment ”

Soheir Ghonemy, Abeer Alarawi, Hagar Bessar

10% topical minoxidil 5% topical minoxidil placebo male androgenetic alopecia trichoscopic evaluation hair growth hair loss adverse effects AGA Rogaine androgenic alopecia

TLDR 10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.

A study compared the effectiveness and safety of a new 10% topical minoxidil solution to a 5% solution and a placebo in treating male androgenetic alopecia. The study concluded that the 10% solution was more effective than the 5% solution and placebo in promoting hair growth and reducing hair loss, with no significant adverse effects reported. The study lasted for 36 weeks and included patients with grades II-VII AGA.

View this study on tandfonline.com →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version

145 citations, November 2017 in “Journal of The European Academy of Dermatology and Venereology”

Use minoxidil for hair loss treatment; assess results after 6 months.

research Classification of Male-Pattern Hair Loss

9 citations, January 2017 in “International Journal of Trichology”

No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.

research Androgenetic Alopecia: An Update Of Treatment Options

110 citations, August 2016 in “Drugs”

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

research Minoxidil May Suppress Androgen Receptor-Related Functions

24 citations, April 2014 in “Oncotarget”

Minoxidil can reduce functions related to androgen receptors.

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

research A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

142 citations, August 2007 in “Journal of The American Academy of Dermatology”

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

research Evaluation and Treatment of Male and Female Pattern Hair Loss

203 citations, December 2004 in “Journal of The American Academy of Dermatology”

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

research Burden of Hair Loss: Stress and the Underestimated Psychosocial Impact of Telogen Effluvium and Androgenetic Alopecia

162 citations, August 2004 in “Journal of Investigative Dermatology”

Hair loss causes stress and affects mental health; treatment and support needed.

A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men

research A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men

269 citations, August 2002 in “Journal of The American Academy of Dermatology”

5% minoxidil works better for hair growth and density, with minor irritation.

Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment

research Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment

115 citations, November 1999 in “Journal of The American Academy of Dermatology”

Minoxidil increases hair weight and count temporarily in men with hair loss.

research Fortnightly Review: Male Pattern Androgenetic Alopecia

179 citations, September 1998 in “BMJ”

Hair loss in men is common, treatable, but not curable.

Related Research

4 / 4 results

research Pustular Dermatosis of the Scalp Due to Topical Minoxidil 5%

3 citations, January 2018

A woman had an unusual allergic reaction to a hair loss treatment, which cleared up after stopping the treatment and using a different medication.

research A Randomized, Placebo-Controlled Trial of 1% Topical Minoxidil Solution in the Treatment of Androgenetic Alopecia in Japanese Women

10 citations, January 2007 in “PubMed”

1% topical minoxidil solution significantly improved hair growth in Japanese women with androgenetic alopecia, with no major side effects.

research Multicenter Double Blind Randomized Placebo Controlled Clinical Trial of Minoxidil Gel in the Treatment of Alopecia Areata

January 2006 in “The Chinese Journal of Clinical Pharmacology”

research Alopecia Areata Treated With Topical Minoxidil

16 citations, April 1984 in “Archives of Dermatology”

Topical minoxidil can help hair regrowth in alopecia areata patients, but maintaining the growth after stopping treatment is inconsistent.